Skip to main content

Table 5 Secondary structure prediction of HPV-33/58 E6 and E7

From: Identification of variants and therapeutic epitopes in HPV-33/HPV-58 E6 and E7 in Southwest China

Target protein

Sequence type

No. helix/Helicesa

No. sheet/Sheetsb

No. coil/Coilsc

Accessibility type

Burred

Exposed

HPV-33 E6

Reference

41/27.52%

31/20.80%

77/51.68%

50/33.56%

99/66.44%

 

Variant

42/28.19%

24/16.11%

83/55.70%

49/32.89%

100/67.11%

HPV-58 E6

Reference

41/27.52%

25/16.78%

83/55.70%

48/32.22%

101/67.78%

 

Variant

42/28.19%

25/16.78%

82/55.03%

48/32.22%

101/67.78%

HPV-33 E7

Reference

12/12.37%

16/16.50%

69/71.13%

27/27.84%

70/72.16%

 

Variant-1

11/11.34%

16/16.50%

70/72.16%

30/30.93%

67/69.07%

 

Variant-2

11/11.34%

16/16.50%

70/72.16%

28/28.87%

69/71.13%

HPV-58 E7

Reference

12/12.24%

17/17.35%

69/70.41%

28/28.57%

70/71.43%

 

Variant-1

12/12.24%

17/17.35%

69/70.41%

26/26.53%

72/73.47%

 

Variant-2

12/12.24%

17/17.35%

69/70.41%

26/26.53%

72/73.47%

  1. Note: In the sequence type column, ‘reference’ and ‘variant’ indicate the reference sequence and variant sequence of the corresponding protein, respectively. ‘No. helix/Helicesa’, ‘No. sheet/Sheetsb’ and ‘No. coil/Coilsc’ represent the number/ratio of residues located in helix, sheet and coil, respectively. ‘Burred’ and ‘Exposed’ represent the number/ratio of residues burred in protein and exposed at the surface, respectively